바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

한국심리학회지: 일반

조현병 음성증상의 심리치료에 대한 개관

Psychosocial Approaches to Negative Symptoms of Schizophrenia: A Comprehensive Systematic Review

한국심리학회지: 일반 / Korean Journal of Psychology: General, (P)1229-067X; (E)2734-1127
2014, v.33 no.4, pp.875-902
최혜임 (고려대학교)
최기홍 (고려대학교)
제갈은주 (고려대학교 심리학과)
송명주 (고려대학교)
  • 다운로드 수
  • 조회수

초록

본 논문에서는 조현병 음성증상에 대한 최신 구성개념을 소개하고 관련 연구들을 체계적으로 개관한 후, 이러한 구성개념을 지지하는 신경과학적 증거들을 살펴보았다. 또한 음성증상의 평가를 위한 기존 측정 도구들과 최신 도구들을 소개하고, 현재까지 조현병 음성증상 치료에 대한 주요 접근법인 인지치료, 행동치료, 동기강화기법, 약물치료 연구들을 개관하였다. 본 논문에서 개관한 음상증상에 대한 최신 구성개념(즉, 음성증상 2요인 모델)에 기반하여, 동기강화와 표현증진, 자기 효능감 향상이라는 요소들을 포함한 새로운 심리사회적 치료 모델을 제시하였다. 본 연구자들이 새롭게 개발하고 있는 조현병 음성증상을 위한 동기행동활성화 치료는 인지 모델 및 학습 모델을 근거로 행동활성화기법과 동기강화기법을 통합하였고, 이러한 동기행동활성화 치료의 실행가능성 및 예비연구 결과를 보고하였다. 동기행동활성화 치료의 예비연구 결과, 음성증상이 있는 조현병 환자에게 실시하였을 때 만족도가 높았으며, 음성증상 평가척도, 동기 및 자기효능감 척도에서 중간 정도의 효과크기를 나타내었다. 마지막으로 조현병 음성증상에 대한 심리치료의 가능성 및 앞으로의 연구방향에 대해 논의하였다.

keywords
조현병, 음성증상, 인지행동치료, 행동활성화기법, 동기강화기법, schizophrenia, negative symptom, cognitive behavior therapy, behavioral activation, motivation interviewing

Abstract

This comprehensive review aimed to introduce 1) the latest concept and research findings on negative symptoms of schizophrenia, 2) existing negative symptom assessment tools, and 3) psycho-social approaches to negative symptoms including cognitive therapy, behavior therapy, motivational interviewing and medications. Based on the latest concept of negative symptoms, motivational theories and learning principles outlined in this paper, a novel psychosocial treatment model (i.e., activation of behavior and motivation for negative symptoms, ABM-NS) was proposed. Finally, we presented data from a feasibility and preliminary efficacy trial. The results indicated that the ABM-NS appeared acceptable to individuals with schizophrenia with negative symptoms, with minimal dropouts and high levels of therapy adherence. Implications and future research directions were discussed.

keywords
조현병, 음성증상, 인지행동치료, 행동활성화기법, 동기강화기법, schizophrenia, negative symptom, cognitive behavior therapy, behavioral activation, motivation interviewing

참고문헌

1.

전임홍, 이수영, 선자연, 송선미, 백수연, 이희영, 조혜현, 신경백, 박종석, 박지인, 송윤영, 안석균 (2013). 정신증을 이해하고 전문가가 되기 위한 조현 인지치료. 서울: 학지사.

2.

American Psychiatric Association. (2000). DSM-IVTR. Washington, D.C.: American Psychiatric Association.

3.

American Psychiatric Association. (2013). DSM-5. Washington, D.C.: American Psychiatric Association.

4.

Arkowitz, H., Westra, H. A., Miller, W. R., & Rollnick, S. (2008). Motivational interviewing in the treatment of psychological problems., NY:Guilford Press.

5.

Beck, A. T., Rector, N. A., Stolar, N. M., Grant, P. M. (2009). Schizophrenia: Cognitive Theory, Research and Therapy. New York: Guilford Press.

6.

Deci, E. L. (1975). Intrinsic Motivation-Perspectives in Social Psychology. New York: Plenum.

7.

Deci, E, L., Ryan, R. M. (1985). Intrinsic motivation and self-determination in human behavior. New York: Plenum.

8.

Alphs, L. D., Summerfelt, A., Lann, H., & Muller, R. J. (1988). The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia. Psychopharmacology Bulletin, 25, 159-163.

9.

Andreasen, N. C. (1982). Negative symptoms in schizophrenia: definition and reliability. Archives of General Psychiatry, 39, 784-788.

10.

Axelrod, B. N., Goldman, R. S., & Alphs, L. D. (1993). Validation of the 16-item negative symptom assessment. Journal of Psychiatric Research, 27, 253-258.

11.

Bach, D. M., & Dowd, E. C. (2010). Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophrenia Bulletin, 36, 919-934.

12.

Bell, M. D., Corbera, S., Johannesen, J. K., Fiszdon, J. M., & Wexler, B. E. (2013). Social cognitive impairments and negative symptoms in schizophrenia: are there subtypes with distinct functional correlates?. Schizophrenia Bulletin. 39, 186-196.

13.

Blanchard, J. J., Mueser, K. T., & Bellack, A. S. (1998). Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophrenia Bulletin, 24, 413-424.

14.

Bor, J., Brunelin, J., d'Amato, T., Costes, N., Suaud-Chagny, M. F., Saoud, M., & Poulet, E. (2011). How can cognitive remediation therapy modulate brain activations in schizophrenia?: An fMRI study. Psychiatry Research: Neuroimaging, 192, 160-166.

15.

Brekke, J. S., Kohrt, B., & Green, M. F. (2001). Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. Schizophrenia Bulletin, 27, 697-708.

16.

Brier, A., Schreiber, J. L., Dyer, J., & Pickar, D. (1991). National Institute of Mental Health longitudinal study of chronic schizophrenia:prognosis and predictors of outcome. Archives of General Psychiatry, 48, 239-246.

17.

Buchanan, R. W. (2007). Persistent negative symptoms in schizophrenia: an overview. Schizophrenia Bulletin, 33, 1013-1022.

18.

Carpenter Jr, W. T., Heinrichs, D. W., & Alphs, L. D. (1985). Treatment of negative symptoms. Schizophrenia Bulletin, 11, 440-452.

19.

Choi, K. H., Saperstein, A. M., & Medalia, A. (2012). The relationship of trait to state motivation: The role of self-competency beliefs. Schizophrenia Research, 139, 73-77.

20.

Cohen, A. S., Dinzeo, T. J., Nienow, T. M., Smith, D. A., Singer, B., & Docherty, N. M. (2005). Diminished emotionality and social functioning in schizophrenia. The Journal of Nervous and Mental Disease, 193, 796-802.

21.

Cohen, A. S., & Minor, K. S. (2010). Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies. Schizophrenia Bulletin, 36, 143-150.

22.

Cuijpers, P., Van Straten, A., & Warmerdam, L. (2007). Behavioral activation treatments of depression: A meta-analysis. Clinical Psychology Review, 27, 318-326.

23.

Depue, R. A., Dubicki, M. D., & McCarthy, T. (1975). Differential recovery of intellectual, associational, and psychophysiological functioning in withdrawn and active schizophrenics. Journal of Abnormal Psychology, 84, 325-330.

24.

Depue, R. A., Morrone-Strupinsky, J. V. (2005). A neurobehavioral model of affiliative bonding:Implications for conceptualizing a human trait of affiliation. Behavioral and Brain Sciences, 28, 313-349.

25.

DeVries, M. W., & Delespaul. P. A. (1989). Time, context, and subjective experience in schizophrenia. Schizophrenia Bulletin, 15, 233-244.

26.

Dobson, D. J., McDougall, G., Busheikin, J., & Aldous, J. (1995). Effects of social skills training and social milieu treatment on symptoms of schizophrenia. Psychiatric Services, 46, 376-380.

27.

Ekers, D., Richards, D., & Gilbody, S. (2008). A meta-analysis of randomized trials of behavioral treatment of depression. Psychological Medicine, 38, 611-623.

28.

Elis, O., Caponigro, J, M., & Kring, A, M. (2013). Psychosocial treatments for negative symptoms in schizophrenia: Current practices and future directions. Clinical Psychology Review, 33, 914-928.

29.

Foussias, G., & Remington, G. (2010). Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophrenia Bulletin, 36, 359-369.

30.

Fowles, D. C. (1988). Psychophysiology and psychopathology: A motivational approach. Psychophysiology, 25, 373-391.

31.

Fusar-Poli, P., & Meyer-Lindenberg, A. (2012). Striatal presynaptic dopamine in schizophrenia, Part II: meta-analysis of [18F/11C]-DOPA PET studies. Schizophrenia Bulletin, 39, 33-42.

32.

Fusar-Poli, P., & Meyer-Lindenberg, A. (2013). Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter(DAT) density. Schizophrenia Bulletin, 39, 22-32.

33.

Gold, J. M., Waltz, J. A., Prentice, K. J., Morris, S. E., & Heerey, E. A. (2008). Reward processing in schizophrenia: a deficit in the representation of value. Schizophrenia Bulletin, 34, 835-847.

34.

Gould, R. A., Mueser, K. T., Bolton E., Mays, V., & Goff, D. (2001). Cognitive therapy for psychosis in schizophrenia: an effect size analysis. Schizophrenia Research, 48, 335-342.

35.

Grant, P. M., Beck, A. T. (2009). Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. Schizophrenia Bulletin, 35, 798-806.

36.

Grant, P. M., Huh, G. A., Perivoliotis, D., Stolar, N. M., & Beck, A. T. (2012). Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Archives of General Psychiatry, 69, 121-127.

37.

Harrow, M., Grinker, R. R., Holzman, P. S., & Kayton, L. (1977). Anhedonia and schizophrenia. The American Journal of Psychiatry, 134, 794-797.

38.

Harter, S. (1978). Effectance motivation reconsidered. Toward a developmental model. Human Development, 21, 34-64.

39.

Haut, K. M., Lim, K. O., & MacDonald, A. (2010). Prefrontal cortical changes following cognitive training in patients with chronic schizophrenia: effects of practice, generalization, and specificity. Neuropsychopharmacology, 35, 1850-1859.

40.

Heerey, E. A., Robinson, B. M., McMahon, R. P., & Gold, J. M. (2007). Delay discounting in schizophrenia. Cognitive Neuropsychiatry, 12, 213-221.

41.

Heerey, E. A., Matveeva, T. M., & Gold, J. M. (2011). Imagining the future: degraded representations of future rewards and events in schizophrenia. Journal of Abnormal Psychology, 120, 483-489.

42.

Heinssen, R. K., Liberman, R. P., & Kopelowicz, A. (2000). Psychosocial skills training for schizophrenia: Lessons from the laboratory. Schizophrenia Bulletin, 26, 21-46.

43.

Herbener, E. S., Harrow, M., & Hill, S. K. (2005). Change in the relationship between anhedonia and functional deficits over a 20-year period in individuals with schizophrenia. Schizophrenia. Research, 75, 97-105.

44.

Herbener, E. S. (2008). Emotional memory in schizophrenia. Schizophrenia Bulletin, 34, 875-887.

45.

Hill, K., & Startup, M. (2013). The relationship between internalized stigma, negative symptoms and social functioning in schizophrenia: The mediating role of self-efficacy. Psychiatry Research, 206, 151-157.

46.

Hodos, W. (1961). Progressive ratio as a measure of reward strength. Science, 134, 943-944.

47.

Horan, W. P., Kring, A. M., Gur, R. E., Reise, S. P., & Blanchard, J. J. (2011). Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophrenia Research, 132, 140-145.

48.

Jacobson, N. S., Dobson, K. S., Truax, P. A., Addis, M. E., Koerner, K., Gollan, J. K., Gortner, E., & Prince, S. E. (1996). A component analysis of cognitive-behavioral treatment for depression. Journal of Consulting and Clinical Psychology, 64, 295-304.

49.

Kay, S. R., Flszbein, A., Opfer, L. A. (1987). The positive and negative syndrome scale(PANSS)for schizophrenia. Schizophrenia Bulletin, 13, 261-276.

50.

Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006). The NIMHMATRICS consensus statement on negative symptoms. Schizophrenia Bulletin, 32 , 214-219.

51.

Kirkpatrick, B., Strauss, G. P., Nguyen, L., Fischer, B. A., Daniel, D. G., Cienfuegos, A., & Marder, S. R. (2011). The brief negative symptom scale: Psychometric properties. Schizophrenia Bulletin, 37, 300-305.

52.

Kokes, R. F., Strauss, J. S., & Klorman, R. (1977). Part II. Measuring Premorbid Adjustment: The Instruments and Their Development. Schizophrenia Bulletin, 3, 186-213.

53.

Konstantakopoulos, G., Ploumpidis, D., Oulis, P., Patrikelis, P., Soumani, A., Papadimitriou, G. N., & Politis, A. M. (2011). Apathy, cognitive deficits and functional impairment in schizophrenia. Schizophrenia Research, 133, 193-198.

54.

Kring, A. M., & Elis, O. (2013). Emotion deficits in people with schizophrenia. Annual review of clinical psychology, 9, 409-433.

55.

Lejuez, C. W., Hopko, D. R., & Hopko, S. D. (2001). A brief behavioral activation treatment for depression treatment manual. Behavior Modification, 25, 255-286.

56.

Mairs, H., Lovell, K., Campbell, M., & Keeley, P. (2011). Development and pilot investigation of behavioral activation for negative symptoms. Behavior Modification, 35, 486-506.

57.

Marder, S. R., Davis, J. M., & Chouinard, G. (1997). The effects of risperidoneon the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. Journal of Clinical Psychiatry, 58, 538-546.

58.

Mazzucchelli, T., Kane, R., & Rees, C. (2009). Behavioral activation treatments for depression in adults: A meta-analysis and review. Clinical Psychology: Science and Practice, 16, 383-411.

59.

Messinger, J. W., Trémeau, F., Antonius, D., Mendelsohn, E., Prudent, V., Stanford, A. D., & Malaspina, D. (2011). Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clinical Psychology Review, 31, 161-168.

60.

Milev, P., Ho, B. C., Arndt, S., & Andreasen, N. C. (2005). Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: A longitudinal first-episode study with 7-year follow up. American Journal of Psychiatry, 162, 495–506.

61.

Miller, D. D., Arndt, S., Andreasen, N. C. (1993). Alogia, attentional impairment, and inappropriate affect: their status in the dimensions of schizophrenia. Comprehensive Psychiatry, 34, 221-226.

62.

Mishlove, M., & Chapman, L. J. (1985). Social anhedonia in the prediction of psychosis proneness. Journal of Abnormal Psychology, 94, 384-396.

63.

Morrison, R. L., & Bellack, A. S. (1987). Social Functioning of Schizophrenic Patients: clinical and research issues. Schizophrenia Bulletin, 13, 715-725.

64.

Penn, D. L., & Mueser, K. T. (1996). Research update on the psychosocial treatment of schizophrenia. American Journal of Psychiatry, 153, 607-617.

65.

Penn, D. L., Roberts, D. L., Combs, D., & Sterne, A. (2007). Best practices: The development of the social cognition and interaction training program for schizophrenia spectrum disorders. Psychiatric Services, 58, 449-451.

66.

Perivoliotis, D., & Cather, C. (2009). Cognitive behavioral therapy of negative symptoms. Journal of Clinical Psychology, 65, 815-830.

67.

Pogue-Geile, M. F., & Harrow, M. (1985). Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Schizophrenia Bulletin, 11, 427-439.

68.

Rector, N. A., & Beck, A. T. (2001). Cognitive behavioral therapy for schizophrenia: an empirical review. Journal of Nervous and Mental Disease, 189, 278-287.

69.

Rector, N. (2004). Dysfunctional attitudes and symptom expression in schizophrenia:differential associations with paranoid delusions and negative symptoms. Journal of Cognitive Psychotherapy, 18, 163-173.

70.

Rector, N. A., Beck, A. T., & Stolar, N. (2005). The negative symptoms of schizophrenia: a cognitive perspective. Canadian Journal of Psychiatry, 50, 247-257.

71.

Reis, H. T. (1994). Domains of experience:Investigating relationship processes from three perspectives. Theoretical Frameworks for Personal Relationships, 87-110.

72.

Ryan, R. M, & Connell, J. P. (1989). Perceived locus of causality and internalization:examining reasons for acting in two domains. Journal of Personality and Social Psychology, 57, 749-761.

73.

Ryan, R. M., Kuhl, J., & Deci, E. L. (1997). Nature and autonomy: An organizational view of social and neurobiological aspects of self-regulation in behavior and development. Development and Psychopathology, 9, 701-728.

74.

Ryan, R. M., & Deci, E. L. (2000). Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. American Psychologist, 55, 68-78.

75.

Salamone, J. D., Cousins, M. S., & Bucher, S. (1994). Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behavior Brain Research, 65, 221-229.

76.

Sanchez, P., Pena, J., Bengoetxea, E., Ojeda, N., Elizagarate, E., Ezcurra, J., & Gutierrez, M. (2014). Improvements in negative symptoms and functional outcome after a new generation cognitive remediation program: a randomized controlled trial. Schizophrenia Bulletin, 40, 707-715.

77.

Sayers, S. L., Curran, P. J., & Mueser, K. T. (1996). Factor structure and construct validity of the Scale for the Assessment of Negative Symptoms. Psychological Assessment, 8, 269-280.

78.

Strauss, G. P., Harrow, M., Grossman, L. S., & Rosen, C. (2010). Periods of Recovery in Deficit Syndrome Schizophrenia: A 20-Year Multi-follow-up Longitudinal Study. Schizophrenia Bulletin, 36, 788-799.

79.

Strauss, G. P., Frank, M. J., Waltz, J. A., Kasanova, Z., Herberner, E. S., & Gold, J. M. (2011). Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia. Biological Psychiatry, 69, 424-431.

80.

Strauss, G. P. (2013). The emotion paradox of anhedonia in schizophrenia: or is it? Schizophrenia Bulletin, 39, 247-250.

81.

Strauss, G. P., Horan, W. P., Kirkpatrick, B., Fischer, B. A., Keller, W. R., Miski, P., . . . Carpenter Jr., W. T. (2013). Deconstructing negative symptoms of schizophrenia:Avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. Journal of Psychiatric Research. 47, 783-790.

82.

Strauss, G. P., Waltz, J. A., & Gold, J. M. (2014). A Review of Reward Processing and Motivational Impairment in Schizophrenia. Schizophrenia Bulletin, 40, S107-S116.

83.

Tarrier, N., Wykes, T. (2004). Is there evidence that cognitive behavior therapy is an effective treatment of schizophrenia? A cautious or cautionary tale?. Behaviour Research and Therapy, 42, 1377-1401.

84.

Waltz, J. A., Frank, M. J., Wiecki, T. V., & Gold, J. M. (2011). Altered probabilistic learning and response biases in schizophrenia:behavioral evidence and neurocomputational modeling. Neuropsychology, 25, 86-97.

85.

Ward, R. D., Simpson, E. H., Richard, V. L., Deo, G., Taylor, K, Glendinning, J. I., ... & Balsam, P. D. (2012), Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia. Neuropsychopharmacology, 37. 1699-1707.

86.

Wykes, T., Huddy, V., Cellard, C., McGurk, S. R., & Czobor, P. (2011). A meta-analysis of cognitive remediation for schizophrenia:methodology and effect sizes. American Journal of Psychiatry, 168, 472-485.

87.

Yi, J. S., Ahn, Y. M., Shin, H. K., An, S. K., Joo, Y. H., Kim, S. H., ... & Kim, Y. S. (2001). Reliability and validity of the Korean version of the Positive and Negative Syndrome Scale. Journal of Korean Neuropsychiatric Association, 40, 1090-1105.

한국심리학회지: 일반